High-throughput strategy for molecular identification of Vel- blood donors employing nucleic acids extracted from plasma pools used for viral nucleic acid test screening
Carregando...
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
BOSI, Silvia R. A.
VEGA, Sileni
SALLES, Nanci A.
Citação
TRANSFUSION, v.56, n.6, p.1430-1434, 2016
Resumo
BACKGROUNDSerologic methods to determine the Vel- phenotype require the use of rare human antisera and do not allow for many samples to be tested simultaneously, which limits their application as a tool to search for rare donors. This study developed a low-cost molecular screening strategy using real-time polymerase chain reaction (PCR) and DNA, extracted from plasma pools for viral nucleic acid test (NAT) screening, to identify Vel- and Vel+(W) donors. STUDY DESIGN AND METHODSA total of 4680 blood donors from the Brazilian southeast region were genotyped through real-time PCR targeting the 17-nucleotide (c.64_80del) deletion in the SMIM1 gene, which determines the Vel- phenotype, by using remaining nucleic acid from plasma pools of six donors, routinely discarded after the release of viral NAT results. RESULTSTwenty pools tested reactive and individual testing of samples from reactive pools identified 19 heterozygous donors with the SMIM1*64_80del deletion (0.40%) and one homozygous donor (0.02%). Fourteen of the 19 donors were confirmed as Vel- or Vel+(W) using anti-Vel human antiserum. CONCLUSIONThe DNA pool genotyping strategy using real-time PCR designed to detect the deletion in the SMIM1 gene proved effective and accurate in identifying donors with the Vel- and Vel+(W) phenotypes. The fact that remaining nucleic acid from routine viral NAT screening was used makes this technique economically attractive and definitely superior to the serologic techniques available to search for this rare phenotype.
Palavras-chave
Referências
- Andrea P, 2015, TRANSFUSION MED, V25, P125, DOI 10.1111/tme.12180
- Ballif BA, 2013, EMBO MOL MED, V5, P751, DOI 10.1002/emmm.201302466
- Brecher M, 2005, TECHNICAL MANUAL
- Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603
- Daniels G., 2013, HUMAN BLOOD GROUPS
- Haer-Wigman L, 2015, TRANSFUSION, V55, P1457, DOI 10.1111/trf.13014
- Rozman P, 2000, TRANSFUSION, V40, P936, DOI 10.1046/j.1537-2995.2000.40080936.x
- Seltsam A, 2003, TRANSFUSION, V43, P1563, DOI 10.1046/j.1537-2995.2003.00565.x
- Storry JR, 2013, NAT GENET, V45, P537, DOI 10.1038/ng.2600
- Sussman LN, 1952, VEL REV HEMATOL, V7, P368